Drug General Information
Drug ID
D07DAP
Former ID
DNC013969
Drug Name
4,4'-(ethane-1,2-diyl)dibenzene-1,3-diol
Drug Type
Small molecular drug
Indication Discovery agent Investigative [529682]
Structure
Download
2D MOL

3D MOL

Formula
C14H14O4
Canonical SMILES
C1=CC(=C(C=C1O)O)CCC2=C(C=C(C=C2)O)O
InChI
1S/C14H14O4/c15-11-5-3-9(13(17)7-11)1-2-10-4-6-12(16)8-14(10)18/h3-8,15-18H,1-2H2
InChIKey
WKIFTWPZTZUMRN-UHFFFAOYSA-N
PubChem Compound ID
Target and Pathway
Target(s) Tyrosine oxidase Target Info Inhibitor [529682]
BioCyc Pathway (S)-reticuline biosynthesis
Eumelanin biosynthesis
L-dopachrome biosynthesis
KEGG Pathway Tyrosine metabolism
Riboflavin metabolism
Metabolic pathways
Melanogenesis
PathWhiz Pathway Riboflavin Metabolism
Tyrosine Metabolism
WikiPathways Dopamine metabolism
References
Ref 529682Bioorg Med Chem Lett. 2008 Oct 1;18(19):5252-4. Epub 2008 Aug 22.Molecular design of potent tyrosinase inhibitors having the bibenzyl skeleton.
Ref 529682Bioorg Med Chem Lett. 2008 Oct 1;18(19):5252-4. Epub 2008 Aug 22.Molecular design of potent tyrosinase inhibitors having the bibenzyl skeleton.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.